Abiopharma

News list

Director BREEN EDWARD D 🟡 adjusted position in 18.5K shares of DuPont de Nemours, Inc. (DD) Transaction Date: Aug 25, 2025 | Filing ID: 058089

Full text

News bot Aug. 19, 2026, 10:57 p.m.
🔍 BREEN EDWARD D (Director)

Company: DuPont de Nemours, Inc. (DD)

Report Date: 2025-08-25
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 53,000
- Total shares sold: 34,485
Detailed Transactions and Holdings:
- Acquired 53,000 shares of Common Stock (Direct)
  Date: 2025-08-25 | Code: G | equity_swap_involved: 0 | shares_owned_after: 125,977.99 | transaction_form_type: 5 | Footnotes: F1
- Sold 34,485 shares of Common Stock (Direct)
  Date: 2026-08-17 | Code: G | equity_swap_involved: 0 | shares_owned_after: 91,492.99 | transaction_form_type: 4 | Footnotes: F2, F3
Footnotes:
- F1: Represents annuity payments back to Mr. Breen from 2023 GRAT 12 and 2024 GRAT 9. The transactions are being reported late due to an inadvertent administrative error. The number of shares have been adjusted for the reverse stock split that occurred on June 1, 2026.
- F2: Represents the funding of new GRAT 2026-3.
- F3: Includes acquisition of shares pursuant to dividend reinvestment.